Compare FMC Corp (FMC) vs US Bancorp (USB) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

U.S. Bancorp (USB) trades at $63.87, up 2.78% with bullish technical signals and strong fundamentals. The stock shows consistent earnings beats (Q4 2025: $1.26 vs $1.19 expected; Q1 2026: $1.18 vs $1.14 expected) and record revenue growth driven by loan expansion and the BTIG acquisition. Analyst consensus is mixed with a $67 price target, while cash flow trends indicate strategic investments despite negative net flows. Recent news highlights robust Q2 2026 performance and new small business payment solutions.

Outlook remains positive with earnings momentum and dividend stability, though risks include interest rate sensitivity and elevated debt levels. The stock presents value at a P/E of 13.21, with upside potential if loan growth sustains. Key watchpoints are Q2 2026 earnings results and Federal Reserve policy impacts on net interest income.